Matches in Wikidata for { <http://www.wikidata.org/entity/Q99614331> ?p ?o ?g. }
- Q99614331 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99614331 description "scientific article published on 18 September 2020" @default.
- Q99614331 description "wetenschappelijk artikel" @default.
- Q99614331 description "наукова стаття, опублікована 18 вересня 2020" @default.
- Q99614331 name "Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase" @default.
- Q99614331 name "Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase" @default.
- Q99614331 type Item @default.
- Q99614331 label "Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase" @default.
- Q99614331 label "Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase" @default.
- Q99614331 prefLabel "Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase" @default.
- Q99614331 prefLabel "Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase" @default.
- Q99614331 P1433 Q99614331-CD26EDD5-9D2F-4A39-B51E-9089A823E4BE @default.
- Q99614331 P1476 Q99614331-D6FDC5E3-5255-42DE-9834-62C7C04884CB @default.
- Q99614331 P2093 Q99614331-00C933E7-285C-4B8A-BD8F-C36650449B82 @default.
- Q99614331 P2093 Q99614331-016EBAFA-F65E-491B-B2BF-E6F43AABF82F @default.
- Q99614331 P2093 Q99614331-0335FC85-D16E-45D8-BC60-5206D9FE5C26 @default.
- Q99614331 P2093 Q99614331-1BF562EE-3CA9-4443-A5CD-FD79F83C4AB5 @default.
- Q99614331 P2093 Q99614331-2E051B35-DFAE-4652-9E3C-ED7B7D1003BD @default.
- Q99614331 P2093 Q99614331-3214053E-8A97-46AD-8621-889D84BB8186 @default.
- Q99614331 P2093 Q99614331-4122BB99-6892-45F8-AAFD-8E2CF6073CCC @default.
- Q99614331 P2093 Q99614331-55E2806A-D078-4F4C-9F18-AED474E153FC @default.
- Q99614331 P2093 Q99614331-56AC0CDF-85D7-430D-B238-29F9F54F8454 @default.
- Q99614331 P2093 Q99614331-645FC39D-E854-4313-A4D3-F7748B2492F7 @default.
- Q99614331 P2093 Q99614331-785015F2-E2FD-4566-A754-1553AE074B19 @default.
- Q99614331 P2093 Q99614331-C1638FE0-04B9-4D3D-BF6E-AE6554B23E96 @default.
- Q99614331 P2093 Q99614331-C7070071-5704-4164-AF1E-37FD5629712E @default.
- Q99614331 P2093 Q99614331-D7B1C1B8-63DA-4821-9EFA-477258D111BC @default.
- Q99614331 P2093 Q99614331-E195B605-93DA-473E-BB7B-F3E4BAFC4518 @default.
- Q99614331 P2093 Q99614331-E7AEA785-0516-4E48-BC20-5E25B74BEED6 @default.
- Q99614331 P2093 Q99614331-ECF5F28F-DC3D-43CF-AA24-8D916C18FE3C @default.
- Q99614331 P2093 Q99614331-F6886FC4-7C4E-4161-9380-C5C977A360FA @default.
- Q99614331 P2860 Q99614331-03154FBD-9A2A-4A2E-8C9E-3039C378212B @default.
- Q99614331 P2860 Q99614331-14ECCBFA-0F3E-4CC7-9D30-1325C438C1BF @default.
- Q99614331 P2860 Q99614331-220436A1-4C61-4870-84AF-E0AC846F14A7 @default.
- Q99614331 P2860 Q99614331-273E563E-3170-449F-A4F7-0A830C652A82 @default.
- Q99614331 P2860 Q99614331-3370E18C-AD7E-4E88-AD05-F2F299A660D2 @default.
- Q99614331 P2860 Q99614331-35F1FA1D-F1E4-4C26-8A78-64B3D8039F37 @default.
- Q99614331 P2860 Q99614331-39644839-D1EB-440B-B0A5-036D5F29D819 @default.
- Q99614331 P2860 Q99614331-3E9BC00D-F0BB-4E13-9F71-0AD896A200C2 @default.
- Q99614331 P2860 Q99614331-41C3F42B-6259-4596-B634-4F38442ACB5B @default.
- Q99614331 P2860 Q99614331-4CF5B7AA-ECD8-492F-B56C-7F5AD8AE4EED @default.
- Q99614331 P2860 Q99614331-56BFB694-0886-44E3-8E01-19AEF4575D55 @default.
- Q99614331 P2860 Q99614331-5A3C1C75-4914-4428-B5F4-13B622FD780B @default.
- Q99614331 P2860 Q99614331-5D12E3F7-EE9C-4895-B8F0-55369873D560 @default.
- Q99614331 P2860 Q99614331-64F3E40E-755D-46A1-8309-D6459E7BE24F @default.
- Q99614331 P2860 Q99614331-66DC4580-435E-4FF5-9294-03D56EB22339 @default.
- Q99614331 P2860 Q99614331-737916C2-75B2-4636-9988-A6D0081F2B37 @default.
- Q99614331 P2860 Q99614331-7C6AF123-7BCC-4823-864A-CB8C802AA649 @default.
- Q99614331 P2860 Q99614331-85A945B5-940E-47EB-95A6-69B3369E8C9B @default.
- Q99614331 P2860 Q99614331-88A261A4-825E-4615-87A4-18F4A3B8E17F @default.
- Q99614331 P2860 Q99614331-A38F5080-FBC2-481C-BBA8-FAAC1DE8C1AE @default.
- Q99614331 P2860 Q99614331-A54AD6F4-71E7-4BBC-A3C9-091EC86FFE60 @default.
- Q99614331 P2860 Q99614331-B6C5E635-AD91-495E-9B04-91BC9E02A74B @default.
- Q99614331 P2860 Q99614331-B94E04D5-0454-44FC-A209-6E801FC25DFA @default.
- Q99614331 P2860 Q99614331-CACF3A3B-C2AD-4EEF-923A-22875F6F2E80 @default.
- Q99614331 P2860 Q99614331-E1CBD327-A319-4732-B459-0CB437DF7D64 @default.
- Q99614331 P2860 Q99614331-EF963219-12CE-4E5A-BEE0-B988B2A65AE5 @default.
- Q99614331 P2860 Q99614331-F3E23ECD-C705-4B6D-9288-0403F785D5F7 @default.
- Q99614331 P31 Q99614331-A27BA062-7942-4452-AC57-B6BC8EEA4515 @default.
- Q99614331 P356 Q99614331-68FCED6A-0FE6-4C24-B589-6D6E3E6FA519 @default.
- Q99614331 P50 Q99614331-4587910B-BE97-4917-8894-460158C269AD @default.
- Q99614331 P50 Q99614331-4E86CC1A-22FB-4BCD-A1EC-2135B8D32760 @default.
- Q99614331 P577 Q99614331-4A29E98C-CC86-4968-A1BC-B47D51AD119F @default.
- Q99614331 P698 Q99614331-6647D2CE-C41C-46F8-94D6-758C0852ABE4 @default.
- Q99614331 P921 Q99614331-762ACF85-9140-49F4-8904-B60261B990C2 @default.
- Q99614331 P356 S0140-6736(20)31953-X @default.
- Q99614331 P698 32966830 @default.
- Q99614331 P1433 Q939416 @default.
- Q99614331 P1476 "Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial" @default.
- Q99614331 P2093 "Andreas Koehler" @default.
- Q99614331 P2093 "Anh Nguyen Duc" @default.
- Q99614331 P2093 "Carlos H Barrios" @default.
- Q99614331 P2093 "Cristiano Ferrario" @default.
- Q99614331 P2093 "Elizabeth A Mittendorf" @default.
- Q99614331 P2093 "Frédérique Penault-Llorca" @default.
- Q99614331 P2093 "Hong Zhang" @default.
- Q99614331 P2093 "Joohyuk Sohn" @default.
- Q99614331 P2093 "Kevin Punie" @default.
- Q99614331 P2093 "Kyung Hae Jung" @default.
- Q99614331 P2093 "Luciana Molinero" @default.
- Q99614331 P2093 "Mario Liste-Hermoso" @default.
- Q99614331 P2093 "Melinda L Telli" @default.
- Q99614331 P2093 "Nadia Harbeck" @default.
- Q99614331 P2093 "Roberto Hegg" @default.
- Q99614331 P2093 "Shilpen Patel" @default.
- Q99614331 P2093 "Stephen Y Chui" @default.
- Q99614331 P2093 "Vidya Maiya" @default.
- Q99614331 P2860 Q29391607 @default.
- Q99614331 P2860 Q30494798 @default.
- Q99614331 P2860 Q33415041 @default.
- Q99614331 P2860 Q34716590 @default.
- Q99614331 P2860 Q37536367 @default.
- Q99614331 P2860 Q38188183 @default.
- Q99614331 P2860 Q38195674 @default.
- Q99614331 P2860 Q38535887 @default.
- Q99614331 P2860 Q40178893 @default.
- Q99614331 P2860 Q40914660 @default.
- Q99614331 P2860 Q41028400 @default.
- Q99614331 P2860 Q48502110 @default.
- Q99614331 P2860 Q50074147 @default.